Radiopharm Theranostics Limited (RAD.AX)
AUD 0.02
(-8.7%)
AUD 0.02
(-8.7%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 299.22 Thousand AUD | 2.35% |
| 2023 | 292.35 Thousand AUD | 3210.6% |
| 2022 | 8831.00 AUD | 0.0% |
| 2021 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 299.22 Thousand AUD | 2.35% |
| 2024 Q4 | 299.22 Thousand AUD | 0.0% |
| 2024 Q2 | 2.03 Million AUD | 0.0% |
| 2024 Q1 | 2.03 Million AUD | 108.69% |
| 2024 Q3 | -1.05 Million AUD | -151.82% |
| 2023 FY | 292.35 Thousand AUD | 3210.6% |
| 2023 Q3 | 973.99 Thousand AUD | 233.15% |
| 2023 Q1 | 2.13 Million AUD | 17757841.67% |
| 2023 Q4 | 973.99 Thousand AUD | 0.0% |
| 2023 Q2 | 292.35 Thousand AUD | -86.28% |
| 2022 Q4 | -12.00 AUD | 0.0% |
| 2022 FY | 8831.00 AUD | 0.0% |
| 2022 Q3 | -12.00 AUD | -200.0% |
| 2022 Q2 | 12.00 AUD | 0.0% |
| 2022 Q1 | 12.00 AUD | 0.0% |
| 2021 FY | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 99.55% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | -215.136% |
| Biome Australia Limited | 13 Million AUD | 97.7% |
| Patrys Limited | 1.39 Million AUD | 78.537% |
| Orthocell Limited | 5.31 Million AUD | 94.371% |
| Imugene Limited | - AUD | -Infinity% |
| Noxopharm Limited | 2.4 Million AUD | 87.534% |
| PYC Therapeutics Limited | 22.05 Million AUD | 98.644% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 95.988% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 91.94% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | 66.46% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 87.078% |
| CSL Limited | 22.41 Billion AUD | 99.999% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -1660.165% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -1533.341% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 99.661% |
| Starpharma Holdings Limited | 8.28 Million AUD | 96.39% |
| Nanollose Limited | 12.5 Thousand AUD | -2293.633% |
| Memphasys Limited | 60 Thousand AUD | -398.713% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 75.316% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 4.45 Million AUD | 93.28% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | 50.279% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 76.092% |
| Race Oncology Limited | 4 Million AUD | 92.526% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 99.94% |
| Dimerix Limited | 583.47 Thousand AUD | 48.716% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 3.5 Million AUD | 91.465% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 97.4% |
| Alterity Therapeutics Limited | 4.01 Million AUD | 92.555% |
| BTC Health Limited | 16.36 Thousand AUD | -1729.022% |
| Acrux Limited | 5.09 Million AUD | 94.122% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 99.871% |
| Biotron Limited | - AUD | -Infinity% |
| Tissue Repair Ltd | 152.24 Thousand AUD | -96.55% |
| AdAlta Limited | 1.73 Million AUD | 82.781% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | 35.007% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -354.754% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | 36.812% |
| Actinogen Medical Limited | 9.93 Million AUD | 96.987% |
| Immuron Limited | 4.9 Million AUD | 93.897% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 88.482% |